Schedule 13G ownership disclosure

RELMADA THERAPEUTICS, INC.

Security class unavailable · CUSIP: 75955J204

Event date: 2017-10-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,200,000
Percent of class
8.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000944746-17-000004
Form type
SC 13G
Filer
KEMMERER JOHN L III
CIK
CIK 944746
Filed
Oct 31, 2017
Reporting period
Oct 04, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub